Evolent Health (EVH) EV to EBIT (2015 - 2026)

Evolent Health has reported EV to EBIT for 12 years, with the latest figure at 49.3 in Q2 2026.

• On a quarterly basis, EV to EBIT rose 94.96% year-over-year to 49.3 in Q2 2026; TTM through Jun 2026 was 1.1, a 96.37% increase from a year earlier, with the FY2025 full-year figure at 0.65, up 97.68% from the prior year.
• EV to EBIT was 49.3 for Q2 2026 at Evolent Health, down from 8.28 in the prior quarter.
• The five-year high for EV to EBIT was 904.16 in Q3 2025, with the low at 1545.9 in Q4 2022.
• Average EV to EBIT over 5 years is 250.32, with a median of 165.05 recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: EV to EBIT tumbled 957.83% in 2022, then soared 564.21% in 2025.
• Over 5 years, EV to EBIT stood at 1545.9 in 2022, then surged by 89.13% to 168.11 in 2023, then soared by 63.75% to 60.94 in 2024, then soared by 98.93% to 0.65 in 2025, then sank by 7469.48% to 49.3 in 2026.
• The last three EV to EBIT figures came in at 49.3 (Q2 2026), 8.28 (Q1 2026), and 0.65 (Q4 2025), per Business Quant data.